PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

JCI early table of contents for Aug. 1, 2013

2013-08-01
(Press-News.org) Prolactin reduces arthritis inflammation

Inflammatory joint diseases such as rheumatoid arthritis are the result of cartilage damage and loss. Chondrocytes are the only cells that are found in cartilage and their death is linked to decreased cartilage health. In this issue of the Journal of Clinical Investigation, Carmen Clapp and colleagues at the National University of Mexico identify prolactin as a potential treatment for inflammatory joint disease. Prolactin treatment prevented chondrocyte death and associated cartilage degradation. In a rat model of inflammatory arthritis, prolactin treatment reduced inflammation, bone erosion, joint swelling, and pain. This study indicates that prolactin therapy has the potential to relieve many symptoms associated with rheumatoid arthritis and other inflammatory-related diseases.

TITLE: Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis

AUTHOR CONTACT:
Carmen Clapp
National University of Mexico, Queretaro, , MEX
Phone: 52442 2381028; Fax: 52442 2340344; E-mail: clapp@servidor.unam.mx

View this article at: http://www.jci.org/articles/view/69485?key=2d78378940de873cad9b

Identification of a molecule linking bone loss and bone formation

Bone integrity requires skeletal remodeling, which involves both bone formation and resorption. It has been previously shown that the formation of new bone is triggered by degradation of older bone. However, it is unknown how these two processes coordinate for skeletal maintenance. In this issue of the Journal of Clinical Investigation, Sunao Takeshita and colleagues at the National Center for Geriatrics and Gerontology identify a protein, CTHRC1 that is secreted by bone adsorbing cells (osteoclasts) and helps initiate bone formation. The authors found that CTHRC1 secretion in bone coincided with bone remodeling and an increase in bone-producing cells. Mice with osteoclasts that did not produce CTHRC1 had lower bone mass than normal animals. This group also found that as animals aged, Cthrch1 expression decreased, suggesting a role for this molecule in age related bone loss. Together these data imply CTHRC1 as a target for treatment and diagnosis of bone diseases such as osteoporosis.

TITLE: Osteoclast-secreted Cthrc1 in the coupling of bone resorption to formation

AUTHOR CONTACT:
Sunao Takeshita
National Center for Geriatrics and Gerontology, Obu, UNK, JPN
Phone: 81-562-44-5651 ext5047; Fax: 81-562-44-6595; E-mail: sunao@ncgg.go.jp

View this article at: http://www.jci.org/articles/view/69493?key=9b1ed5fcb851687ded70

Defense against bacterial infection in chronic granulomatous disease

Patients suffering from chronic granulomatous disease (CGD) are prone to recurrent and potentially life threatening bouts of infection due to the inability of phagocytic cells to kill invading microorganisms. Normal phagocytes release reactive oxygen compounds in response to infection, but this defense is lacking in phagocytes of people with CGD. In the current issue of the Journal of Clinical Investigation, Griffin Rodgers and colleagues at the National Institutes of Health identify a neutrophil granule protein, OLFM4 as a potential therapeutic target for CGD patients. In a mouse model of CGD, deletion of Olfm4 protected the mice from infection with Staphylococcus aureus. The protective effect of Olmf4 deletion in CGD mice extended to multiple strains of S. aureus, including a community-associated strain of MRSA. This study suggests that targeting OLMF4 in CGD patients may enhance their ability to fight off bacterial infection.

TITLE: Olfm4 deletion enhances defense against Staphylococcus aureus in CGD mice

AUTHOR CONTACT:
Griffin Platt Rodgers
National Institutes of Health, Bethesda, MD, USA
Phone: 301-496-5741; E-mail: gr5n@nih.gov

View this article at: http://www.jci.org/articles/view/68453?key=332f5fa569aa60f1cb13

ALSO IN THIS ISSUE

TITLE: Congenital amegakaryotic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling

AUTHOR CONTACT:
Koji Eto
Center for iPS Cell Research and Application, Kyoto University, Kyoto, JPN
Phone: +81-75-366-7075; Fax: +81-76-366-7095; E-mail: kojieto@cira.kyoto-u.ac.jp

View this article at: http://www.jci.org/articles/view/64721?key=0a6b68c66dec749d3077

TITLE: Myeloperoxidase, paraoxonase-1 and HDL form a functional ternary complex

AUTHOR CONTACT:
Stanley L. Hazen
Cleveland Clinic, Cleveland, OH, USA
Phone: 216-445-9763; Fax: 216-444-9404; E-mail: hazens@ccf.org

View this article at: http://www.jci.org/articles/view/67478?key=246677e58b7424a3044c

TITLE: Mobilizing monocytes to cross-present circulating viral antigen in chronic infection

AUTHOR CONTACT:
Adam Gehring
Saint Louis University, School of Medicine, Saint Louis, MO, USA
Phone: +1 (314) 977-8711; Fax: +1 (314) 977-8717; E-mail: gehringa@slu.edu

View this article at: http://www.jci.org/articles/view/66043?key=fe39ad417022bed4fe30

### END


ELSE PRESS RELEASES FROM THIS DATE:

Prolactin reduces arthritis inflammation

2013-08-01
Inflammatory joint diseases such as rheumatoid arthritis are the result of cartilage damage and loss. Chondrocytes are the only cells that are found in cartilage and their death is linked to decreased cartilage health. In this issue of the Journal of Clinical Investigation, Carmen Clapp and colleagues at the National University of Mexico identify prolactin as a potential treatment for inflammatory joint disease. Prolactin treatment prevented chondrocyte death and associated cartilage degradation. In a rat model of inflammatory arthritis, prolactin treatment reduced inflammation, ...

Identification of a molecule linking bone loss and bone formation

2013-08-01
Bone integrity requires skeletal remodeling, which involves both bone formation and resorption. It has been previously shown that the formation of new bone is triggered by degradation of older bone. However, it is unknown how these two processes coordinate for skeletal maintenance. In this issue of the Journal of Clinical Investigation, Sunao Takeshita and colleagues at the National Center for Geriatrics and Gerontology identify a protein, CTHRC1 that is secreted by bone adsorbing cells (osteoclasts) and helps initiate bone formation. The authors found that CTHRC1 secretion ...

Defense against bacterial infection in chronic granulomatous disease

2013-08-01
Patients suffering from chronic granulomatous disease (CGD) are prone to recurrent and potentially life threatening bouts of infection due to the inability of phagocytic cells to kill invading microorganisms. Normal phagocytes release reactive oxygen compounds in response to infection, but this defense is lacking in phagocytes of people with CGD. In the current issue of the Journal of Clinical Investigation, Griffin Rodgers and colleagues at the National Institutes of Health identify a neutrophil granule protein, OLFM4 as a potential therapeutic target for CGD patients. ...

We each live in our own little world -- smellwise

2013-08-01
There are some smells we all find revolting. But toward a handful of odors, different people display different sensitivities—some can smell them, while some can't, or some find them appealing, while others don't. A pair of studies appearing online on August 1 in the journal Current Biology, a Cell Press publication, now identifies the genetic differences that underpin the differences in smell sensitivity and perception in different individuals. The researchers tested nearly 200 people for their sensitivity for ten different chemical compounds that are commonly found in ...

Neuroscientists find protein linked to cognitive deficits in Angelman syndrome

2013-08-01
A team of neuroscientists has identified a protein in laboratory mice linked to impairments similar to those afflicted with Angelman syndrome (AS)—a condition associated with symptoms that include autism, intellectual disability, and motor abnormalities. The findings appear in the journal Cell Reports. "By isolating a protein that contributes to cognitive deficits in Angelman syndrome, these findings mark a step forward in not only addressing AS, but perhaps other developmental disorders as well," said Eric Klann, a professor in New York University's Center for Neural ...

Boning up: McMaster researchers find home of best stem cells for bone marrow transplants

2013-08-01
Hamilton, ON (August 1, 2013) –McMaster University researchers have revealed the location of human blood stem cells that may improve bone marrow transplants. The best stem cells are at the ends of the bone. It is hoped this discovery will lead to lowering the amount of bone marrow needed for a donation while increasing regeneration and lessening rejection in the recipient patients, says principal investigator Mick Bhatia, professor and scientific director of the McMaster Stem Cell and Cancer Research Institute. In a paper published online today by the journal Cell ...

Bacteria hold the clues to trade-offs in financial investments and evolution

2013-08-01
Scientists have found that bacteria have the potential to teach valuable investment lessons. The research, published in the journal Ecology Letters, takes advantage of the fact that bacteria, like humans, have limited resources and are constantly faced with investment decisions. Bacteria though are successful with their investments and have colonised every inch of the surface of our planet. The researchers, from the Universities of Exeter and Sydney, used mathematical models and lab-based synthetic biology, to predict bacterial investment crashes and boom-bust cycles. ...

UC San Diego researchers develop efficient model for generating human iPSCs

2013-08-01
Researchers at the University of California, San Diego School of Medicine report a simple, easily reproducible RNA-based method of generating human induced pluripotent stem cells (iPSCs) in the August 1 edition of Cell Stem Cell. Their approach has broad applicability for the successful production of iPSCs for use in human stem cell studies and eventual cell therapies. Partially funded by grants from the California Institute for Regenerative Medicine (CIRM) and the National Institutes of Health (NIH), the methods developed by the UC San Diego researchers dramatically ...

Fly study finds 2 new drivers of RNA editing

2013-08-01
PROVIDENCE, R.I. [Brown University] — RNA editing gives organisms a way to adapt the instructions that their DNA provides for making proteins. Few people would have described RNA editing as a simple process, but a new paper in Nature Communications demonstrates the process as more complex and difficult to predict than previously assumed. The study, done in living fruit flies, discovered two new mechanisms that govern editing in a key neurodevelopmental gene. RNA editing is governed not only by sequences of RNA nucleotides (the letters A, C, G, and U) and corresponding ...

Ultrasound patch heals venous ulcers in human trial

2013-08-01
In a small clinical study, researchers administered a new method for treating chronic wounds using a novel ultrasound applicator that can be worn like a band-aid. The applicator delivers low-frequency, low-intensity ultrasound directly to wounds, and was found to significantly accelerate healing in five patients with venous ulcers. Venous ulcers are caused when valves in the veins malfunction, causing blood to pool in the leg instead of returning to the heart. This pooling, called venous stasis, can cause proteins and cells in the vein to leak into the surrounding tissue ...

LAST 30 PRESS RELEASES:

Mysterious ‘Dark Dwarfs’ may be hiding at the heart of the Milky Way

Real-world data shows teclistamab can benefit many multiple myeloma patients who would have been ineligible for pivotal trial

Scientists reveal how a key inflammatory molecule triggers esophageal muscle contraction

Duration of heat waves accelerating faster than global warming

New mathematical insights into Lagrangian turbulence

Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug

Artificial solar eclipses in space could shed light on Sun

Probing the cosmic Dark Ages from the far side of the Moon

UK hopes to bolster space weather forecasts with Europe's first solar storm monitor

Can one video change a teen's mindset? New study says yes - but there’s a catch

How lakes connect to groundwater critical for resilience to climate change, research finds

Youngest basaltic lunar meteorite fills nearly one billion-year gap in Moon’s volcanic history

Cal Poly Chemistry professor among three U.S. faculty to be honored for contributions to chemistry instruction

Stoichiometric crystal shows promise in quantum memory

Study sheds light on why some prostate tumors are resistant to treatment

Tree pollen reveals 150,000 years of monsoon history—and a warning for Australia’s northern rainfall

Best skin care ingredients revealed in thorough, national review

MicroRNA is awarded an Impact Factor Ranking for 2024

From COVID to cancer, new at-home test spots disease with startling accuracy

Now accepting submissions: Special Collection on Cognitive Aging

Young adult literature is not as young as it used to be

Can ChatGPT actually “see” red? New results of Google-funded study are nuanced

Turning quantum bottlenecks into breakthroughs

Cancer-fighting herpes virus shown to be an effective treatment for some advanced melanoma

Eliminating invasive rats may restore the flow of nutrients across food chain networks in Seychelles

World’s first: Lithuanian scientists’ discovery may transform OLED technology and explosives detection

Rice researchers develop superstrong, eco-friendly materials from bacteria

Itani studying translation potential of secure & efficient software updates in industrial internet of things architectures

Elucidating the source process of the 2021 south sandwich islands tsunami earthquake

Zhu studying use of big data in verification of route choice models

[Press-News.org] JCI early table of contents for Aug. 1, 2013